Vacation of injunction upon invalidation of patent by USPTO ePlus. v. Lawson Software
22nd August, 2014 - 11:55 am
Categories:
IP Litigation
News & Updates
Patent Litigation
Patents
USPTO
0 Comments
In a recent judgment, The U.S. Court of Appeals for the Federal Circuit on July 25, 2014, vacated the U.S. District Court’s decision on injunction and contempt orders against Lawson Software and instructed the lower court to dismiss the patent litigation case brought by ePlus, Inc. This decision mainly pertains totwo main issues. Firstly, whether … Continue reading Vacation of injunction upon invalidation of patent by USPTO ePlus. v. Lawson Software
Read more »Patent Trolling and Fee-Shifting
Manish Kumar, intern at Khurana and Khurana, Advocates and IP Attorneys, looks at ‘fee-shifting’ paradigm in US Patent Act in light of US Supreme Court recent judgments. The US Supreme Court, in its two recent judgments, has re-instituted its pre-2005 stand where the Courts had discretion of awarding reasonable attorney fees to the prevailing party … Continue reading Patent Trolling and Fee-Shifting
Read more »Why Protecting Patents in India is Giving Hard Time to Drug Patent Holders
22nd May, 2014 - 10:34 am
Categories:
India
IP Litigation
News & Updates
Patent Litigation
Patents
Pharma/Biotech Patent Litigations
0 Comments
Introduction A lot has been discussed on the Novartis ruling indicating much higher standards of patentability under Indian law under section 3d. The ruling decided that any new form of known compound (in medicine) would be patentable only if there is enhanced ‘therapeutic efficacy’ over the known compound. Post Novartis ruling, a couple of patent … Continue reading Why Protecting Patents in India is Giving Hard Time to Drug Patent Holders
Read more »Relief for Pfizer as IPAB stays Revocation on Drug Tolterodine
19th April, 2014 - 11:28 am
Categories:
IP Litigation
IP Practice in India
IPAB Decisions
News & Updates
Patent Litigation
Patents
0 Comments
In a positive development for US drug giant Pfizer, the country’s Intellectual Property Appellate Board (IPAB) has issued an interim stay on an order stated by the Indian Patent Office removing a patent of Pfizer, for its extended release drug Tolterodine (Detrol), which is used for treating old age patients who suffer from frequent urination. … Continue reading Relief for Pfizer as IPAB stays Revocation on Drug Tolterodine
Read more »IPAB: Nature of Jurisdiction, Power and Authority
2nd January, 2014 - 5:17 am
Categories:
IP Litigation
IP Practice in India
IPAB Decisions
Patent Litigation
Patents
0 Comments
Akash Patel, an intern at Khurana and Khurana, Advocates and IP Attorneys, looks at the nature of jurisdiction at the IPAB, its power and authority. In a judgment dated July 08, 2013, a larger bench of Intellectual Property Appellate Board (hereinafter read as IPAB) had decided on two important issues, one relating to IPAB’s power … Continue reading IPAB: Nature of Jurisdiction, Power and Authority
Read more »Central Government’s power of Revocation of Patent in Public Interest
2nd January, 2014 - 3:10 am
Categories:
IP Litigation
IP Practice in India
Patent Litigation
Patents
0 Comments
Gopikrishnan M and Akash Patel, interns at Khurana and Khurana, Advocates and IP Attorneys, looks at Central Government’s power of Revocation of Patent in Public Interest. The Indian Patent Act,1970(hereinafter Act) empowers the Central Government to revoke any patent granted by the Indian Patent Office if it feels that the said patent is prejudicial to public … Continue reading Central Government’s power of Revocation of Patent in Public Interest
Read more »Rockstar Consortium US LP et. al.v. Google Inc
Gopikrishnan M, an intern at Khurana and Khurana, Advocates and IP Attorneys, looks at Google Inc. been accused of infringing technology related to its searching technology itself. Yet another high-tech and high-profile patent war is on, this one involving a combined attack on the search giant’s core technology. Google is being sued for direct patent infringement … Continue reading Rockstar Consortium US LP et. al.v. Google Inc
Read more »The Billion Dollar Game: Samsung and Apple fight it out
24’th Aug 2012 was another milestone date indicating the value that IP can (of course in geographies which have respect and appreciation for IP!!!) hold and govern for a corporate. More than the award, it’s the injunction and respect for IP that matters and boosts the confidence of Corporates that have innovation as a core … Continue reading The Billion Dollar Game: Samsung and Apple fight it out
Read more »Spice Mobiles Ltd. and M/s. Samsung India Electronics Pvt. Ltd. Vs Shri Somasundaram Ramkumar Revocation Proceeding for IN 214388
16th July, 2012 - 5:50 am
Categories:
Hi Tech Patent Litigation
IP Practice in India
News & Updates
Patent Litigation
0 Comments
In a major decision, the Intellectual Property Appellate Board (IPAB) on 1st June 2012 has revoked a patent IN214388 under section 57, 59 and 64(1)(e)(f) of Indian Patent Act, 1970. In this article, we would discuss certain aspects related to outcome of decision and some arguments put forth by the respondent during the trail. The … Continue reading Spice Mobiles Ltd. and M/s. Samsung India Electronics Pvt. Ltd. Vs Shri Somasundaram Ramkumar Revocation Proceeding for IN 214388
Read more »Tata Chemicals vs. Hindustan Unilever Limited Revocation Proceeding for IN 195937: Would compliance of Section 8 become a nightmare for Patent Applicants?
16th July, 2012 - 5:36 am
Categories:
IP Practice in India
News & Updates
Patent Litigation
0 Comments
This article relates to a recent judgement of IPAB on 12’th July 2012 on revocation of an Indian Patent IN 195937, wherein certain interesting aspects relating to developing standards for revocation under Section 8 of the Indian Patent Act, 1970 have been discussed and put forth, quite strongly!! Case Summary: In summary, the case relates … Continue reading Tata Chemicals vs. Hindustan Unilever Limited Revocation Proceeding for IN 195937: Would compliance of Section 8 become a nightmare for Patent Applicants?
Read more »